Endo ERN
Find an expert
Ukraine
Endo ERN
Search
  • Rare Endocrine Conditions

    Endocrine Conditions

    Endo-ERN is focused on 8 main thematic groups (MTGs) which cover rare and/or complex endocrine conditions

    Go to overview

    Categories

    • MTG1Adrenal
    • MTG2Disorders of Calcium & Phosphate Homeostasis
    • MTG3Genetic Disorders of Glucose & Insulin Homeostasis
    • MTG4Genetic Endocrine Tumour Syndromes
    • MTG5Growth & Genetic Obesity Syndromes
    • MTG6Hypothalamic and Pituitary Conditions
    • MTG7Sex Development & Maturation
    • MTG8Thyroid
  • About Us

    About Us

    Endo-ERN is a network of 100+ Reference Centres (RCs) in 27 EU member states+Norway that offers access to clinical experts for patients with rare endocrine conditions.  

    Go to overview

    Who we are

    • About Endo-ERN
    • What we do
    • Reference centres
    • Work packages
    • Project team

    Information

    • Events
    • FAQ
    • Newsletter
    • Contact
    • ERNs
  • For Professionals

    For Professionals

    Endo-ERN is the network for rare endocrine conditions providing healthcare professionals with access to a variety of resources to support patient care.  

    Our Network

    • About Endo-ERN
    • Find a Reference Centre

    Research

    • Registries
    • Publications
    • Clinical Trials

    Support Tools

    • Virtual Consultations
    • Guidelines
    • COVID-19

    Training & Education

    • Webinars
    • Exchange Programme
  • For Members

    For Members

    If you work at a member institution this page will help with your Endo-ERN contributions.  

    Go to overview

    Quick Links

    • Cite Endo-ERN
    • CPMS 2.0
    • GA2026
    • The Journal

    Evaluation

    • Continuous Monitoring Exercise
    • 5-year evaluation
    • HCP Performance System

    Network Participation

    • Event Endorsement
    • Member Survey
    • Webinar Planning
    • MTG Representatives

    Membership Management

    • Update Member Contacts
    • Request Disease Area Expansion
    • Termination Policy
  • For Patients

    For Patients

    Access to rare disease expertise without the need to travel is a core ERN objective.  Our ePAGs contribute to all Endo-ERN activities.  

    Go to overview

    Patient information

    • What are European Reference Networks?
    • Cross-border healthcare
    • Rare endocrine conditions
    • Patient materials

    ePAG information

    • European Patient Advocacy Groups
    • Patient representatives
    • How to become an Endo-ERN ePAG
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
Endo ERN
Ukraine
Find an expert
Search
/ Publications Overview / Publications Database

Endo-ERN Publications Database

RDD IssuesBack to Publications Overview

Filter list of publications

940 publication(s) found matching the search criteria

Fluctuations in Thyroid Hormone Levels During Initial Treatment for Differentiated Thyroid Carcinoma are Associated with Changes in Hemostasis: A Prospective Cohort Study


Author(s): Links MH, Lefrandt JD, Lisman T, van der Boom T, Lukens MV, Meijer K, Links TP, Zandee WT
Affiliated Institution / ERN: University Medical Center Groningen ;
Condition / Disease: Thyroid cancer
Publication: Thyroid v33.2 p203-213 Year: 2023 ORPHAcode / other: ORPHA146
DOI: 10.1089/thy.2022.0299 Keywords: TH withdrawal,THST,cardiovascular risk,differentiated thyroid carcinoma,hemostasis,thrombosis
MTG8

Continuous glucose monitoring‐based time‐in‐range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head‐to‐head randomized controlled InRange trial


Author(s): Battelino T, Danne T, Edelman SV, Choudhary P, Renard E, Westerbacka J, Mukherjee B, Pilorget V, Coudert M, Bergenstal RM
Affiliated Institution / ERN: University Medical Centre Ljubljana ;
Condition / Disease: Diabetes mellitus
Publication: Diabetes, Obesity and Metabolism v25.2 p545-555 Year: 2023 ORPHAcode / other:
DOI: 10.1111/dom.14898 Keywords: basal insulin,continuous glucose monitoring,glycaemic control,insulin analogues,randomized trial,type 1 diabetes
MTG3

Prospective evaluation of multidimensional health‐related quality of life after endoscopic endonasal surgery for pituitary adenomas using the endoscopic endonasal sinus and skull base surgery questionnaire


Author(s): Joustra GE, ten Dam E, Vermeulen KM, Korsten‐Meijer AGW, Appelman APA, Feijen RA
Affiliated Institution / ERN: University Medical Center Groningen ;
Condition / Disease: Acromegaly
Publication: Laryngoscope Investigative Otolaryngology v8.1 p7-15 Year: 2023 ORPHAcode / other: ORPHA963
DOI: 10.1002/lio2.1004 Keywords: anterior skull base,endoscopic endonasal sinus and Skull Base surgery questionnaire (EES‐Q),endoscopic skull base surgery,patient reported outcome measure,quality of life
MTG6

In Search of the Hyperglycemic Threshold Required to Induce Growth Hormone (GH) Suppression


Author(s): Bugalho MJ, Lopes-Pinto M, Lemos C, Nobre E
Affiliated Institution / ERN: Unidade Local de Saúde de Santa Maria(ULS de Santa Maria) ;
Condition / Disease: Acromegaly
Publication: Cureus doi:10.7759/cureus.34463 Year: 2023 ORPHAcode / other: ORPHA963
DOI: 10.7759/cureus.34463 Keywords: acromegaly,growth hormone,hyperglycemia,oral glucose tolerance test,suppression test
MTG6

Multicentric Italian case–control study on 25OH vitamin D levels in children and adolescents with Prader-Willi syndrome


Author(s): Panfili FM, Convertino A, Grugni G, Mazzitelli L, Bocchini S, Crinò A, Campana G, Cappa M, Delvecchio M, Faienza MF, Licenziati MR, Mariani M, Osimani S, Pajno R, Patti G, Rutigliano I, Sacco M, Scarano E, Fintini D
Affiliated Institution / ERN: San Raffaele hospital - Milan ;
Condition / Disease: Prader-Willi syndrome
Publication: Journal of Endocrinological Investigation v46.7 p1397-1406 Year: 2023 ORPHAcode / other: ORPHA739
DOI: 10.1007/s40618-022-01990-5 Keywords: 25OHD,GH therapy,Insulin resistance,Obesity,Prader-Willi syndrome,Vitamin D
MTG5

Adherence to Acromegaly Treatment and Analysis of the Related Factors—A Real-World Study in Bulgaria


Author(s): Kamusheva M, Vandeva S, Mitov K, Parvanova A, Pesheva M, Ganov N, Rusenova Y, Marinov L, Getova V, Elenkova A, Petrova G
Affiliated Institution / ERN: USHATE “ACAD IVAN Penchev” ;
Condition / Disease: Acromegaly
Publication: Pharmaceutics v15.2 p438 Year: 2023 ORPHAcode / other: ORPHA963
DOI: 10.3390/pharmaceutics15020438 Keywords: Bulgaria,acromegaly,adherence
MTG6

Multicentric Italian case–control study on 25OH vitamin D levels in children and adolescents with Prader-Willi syndrome


Author(s): Panfili FM, Convertino A, Grugni G, Mazzitelli L, Bocchini S, Crinò A, Campana G, Cappa M, Delvecchio M, Faienza MF, Licenziati MR, Mariani M, Osimani S, Pajno R, Patti G, Rutigliano I, Sacco M, Scarano E, Fintini D
Affiliated Institution / ERN: AOU-Bologna ;
Condition / Disease: Prader-Willi syndrome
Publication: Journal of Endocrinological Investigation v46.7 p1397-1406 Year: 2023 ORPHAcode / other: ORPHA739
DOI: 10.1007/s40618-022-01990-5 Keywords: 25OHD,GH therapy,Insulin resistance,Obesity,Prader-Willi syndrome,Vitamin D
MTG5

Mapping of the current transition of care practice for patients with pituitary disease at Endo-ERN reference centers


Author(s): Shishkov SR, Tuccillo L, Iotova VM, Pivonello R, Pelsma IC, Pereira AM, Biermasz NR, and the Endo-ERN Reference Centers of the Main Thematic Group: Hypothalmic and Pituitary Conditions, Endo-ERN Pituitary Transition of Care Study Group
Affiliated Institution / ERN: UMHAT “Sveta Marina” (Varna) ; Leiden University Medical Center ;
Condition / Disease: pituitary conditions; transition survey;
Publication: Endocrine Connections Volume 12: Issue 2 Year: 2023 ORPHAcode / other: ORPHA99408; ORPHA95502
DOI: 10.1530/ec-22-0308 Keywords: Endo-ERN,pituitary disease,quality of care,survey,transition of care
MTG6

Methylation status of hypothalamic Mkrn3 promoter across puberty


Author(s): Fanis P, Morrou M, Tomazou M, Michailidou K, Spyrou GM, Toumba M, Skordis N, Neocleous V, Phylactou LA
Affiliated Institution / ERN: Cyprus Institute of Neurology and Genetics ;
Condition / Disease: Central Precocious Puberty
Publication: Frontiers in Endocrinology v13 Year: 2023 ORPHAcode / other: ORPHA650182
DOI: 10.3389/fendo.2022.1075341 Keywords: CpG island,DNA methylation,MKRN3,promoter,puberty timing
MTG7

Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome


Author(s): Hendricks LAJ, Hoogerbrugge N, Mensenkamp AR, Brunet J, Lleuger-Pujol R, Høberg-Vetti H, Tveit Haavind M, Innella G, Turchetti D, Aretz S, Spier I, Tischkowitz M, Jahn A, Links TP, Olderode-Berends MJW, Blatnik A, Leter EM, Evans DG, Woodward ER, Steinke-Lange V, Anastasiadou VC, Colas C, Villy M, Benusiglio PR, Gerasimenko A, Barili V, Branchaud M, Houdayer C, Tesi B, Yazicioglu MO, van der Post RS, Schuurs-Hoeijmakers JHM, van Hest LP, Adank MA, Duijkers F, Nielsen M, Verbeek KCJ, van Ierland Y, Giltay JC, Vos JR, Vos JR
Affiliated Institution / ERN: University Medical Center Groningen ;
Condition / Disease: Familial Genetic Tumour Syndromes
Publication: JNCI: Journal of the National Cancer Institute v115.1 p93-103 Year: 2023 ORPHAcode / other: ORPHA306498
DOI: 10.1093/jnci/djac188 Keywords:
MTG4

Pre-Surgery Patient Health Contributes to Aggravated Sino-Nasal Outcome and Quality of Life after Pituitary Adenomectomy


Author(s): Chmielewski WX, Walbrodt S, Rauschenbach L, Chihi M, Gembruch O, Darkwah Oppong M, Schroer S, Wrede KH, Dammann P, Jabbarli R, Kreitschmann-Andermahr I, Sato T, Unger N, Mattheis S, Sure U, Ahmadipour Y
Affiliated Institution / ERN: University Hospital Essen ;
Condition / Disease: pituitary adenoma
Publication: Medicina v59.1 p127 Year: 2023 ORPHAcode / other: ORPHA99408
DOI: 10.3390/medicina59010127 Keywords: adenomectomy,health-related quality of life,pituitary adenoma,pre-surgery patient health,sino-nasal health
MTG6

Pediatric growth hormone and prolactin-secreting tumor associated with an AIP mutation and a MEN1 variant of uncertain significance


Author(s): Alexandre MI, Faria CC, Gomes A, Bugalho MJ
Affiliated Institution / ERN: Unidade Local de Saúde de Santa Maria(ULS de Santa Maria) ;
Condition / Disease: Pediatric growth hormone and prolactin secreting tumour
Publication: Journal of Pediatric Endocrinology and Metabolism v0.0 Year: 2023 ORPHAcode / other: ORPHA2965
DOI: 10.1515/jpem-2022-0488 Keywords: genetic testing,gigantism,growth hormone
MTG6

Continuous glucose monitoring and metrics for clinical trials: an international consensus statement


Author(s): Battelino T, Alexander CM, Amiel SA, Arreaza-Rubin G, Beck RW, Bergenstal RM, Buckingham BA, Carroll J, Ceriello A, Chow E, Choudhary P, Close K, Danne T, Dutta S, Gabbay R, Garg S, Heverly J, Hirsch IB, Kader T, Kenney J, Kovatchev B, Laffel L, Maahs D, Mathieu C, Mauricio D, Nimri R, Nishimura R, Scharf M, Del Prato S, Renard E, Rosenstock J, Saboo B, Ueki K, Umpierrez GE, Weinzimer SA, Phillip M
Affiliated Institution / ERN: University Medical Centre Ljubljana ;
Condition / Disease: Continuous glucose monitoring
Publication: The Lancet Diabetes & Endocrinology v11.1 p42-57 Year: 2023 ORPHAcode / other:
DOI: 10.1016/s2213-8587(22)00319-9 Keywords:
MTG3

Congenital adrenal hyperplasia


Author(s): Auer MK, Nordenström A, Lajic S, Reisch N
Affiliated Institution / ERN: Klinikum der Universität München ;
Condition / Disease: Congenital Adrenal Hyperplasia
Publication: The Lancet v401.10372 p227-244 Year: 2023 ORPHAcode / other: ORPHA418
DOI: 10.1016/s0140-6736(22)01330-7 Keywords:
MTG1

COVID-19 forced restrictions did not affect metabolic control in youth with T2D in Italy


Author(s): Zucchini S, Iafusco D, Cherubini V, De Sanctis L, Maltoni G, Lenzi L, Mozzillo E, Calcaterra V, Gallo F, Arnaldi C, Delvecchio M, Rabbone I, Minuto N, Predieri B, Zanfardino A, Piscopo A, Tiberi V, Tinti D, Rapini N, Toni S, Schiaffini R
Affiliated Institution / ERN: Meyer Children’s Hospital Florence ;
Condition / Disease: diabetes type 2
Publication: Nutrition, Metabolism and Cardiovascular Diseases v33.1 p232-233 Year: 2023 ORPHAcode / other:
DOI: 10.1016/j.numecd.2022.10.012 Keywords:
MTG3

Liver fat accumulation more than fibrosis causes early liver dynamic dysfunction in patients with non-alcoholic fatty liver disease


Author(s): Di Ciaula A, Shanmugam H, Ribeiro R, Pina A, Andrade R, Bonfrate L, Raposo JF, Macedo MP, Portincasa P
Affiliated Institution / ERN: APDP – Diabetes Portugal ;
Condition / Disease: non-alcoholic fatty liver disease
Publication: European Journal of Internal Medicine v107 p52-59 Year: 2023 ORPHAcode / other:
DOI: 10.1016/j.ejim.2022.10.024 Keywords: Breath test,Fibroscan,Liver function,Liver steatosis,Liver stiffness,Metabolic-associated fatty liver disease,Non-alcoholic fatty liver disease

Position paper from the Endocrine Task Force of the European Organisation for Research and Treatment of Cancer (EORTC) on the management and shared decision making in patients with low-risk micro papillary thyroid carcinoma


Author(s): Koot A, Soares P, Robenshtok E, Locati LD, de la Fouchardiere C, Luster M, Bongiovanni M, Hermens R, Ottevanger P, Geenen F, Bartѐs B, Rimmele H, Durante C, Nieveen-van Dijkum E, Stalmeier P, Dedecjus M, Netea-Maier R
Affiliated Institution / ERN: Amsterdam UMC ; São João University Hospital(CHUSJ) ;
Condition / Disease: papillary thyroid carcinoma
Publication: European Journal of Cancer v179 p98-112 Year: 2023 ORPHAcode / other: ORPHA146
DOI: 10.1016/j.ejca.2022.11.005 Keywords: Microcarcinoma,Papillary,Shared decision making,Thyroid,Treatment options
MTG8

Multi-omic integration reveals cell-type-specific regulatory networks of insulin resistance in distinct ancestry populations


Author(s): Xu P, Wang M, Sharma NK, Comeau ME, Wabitsch M, Langefeld CD, Civelek M, Zhang B, Das SK
Affiliated Institution / ERN: Ulm University Medical Center ;
Condition / Disease: Insulin-resistance syndrome
Publication: Cell Systems v14.1 p41-57.e8 Year: 2023 ORPHAcode / other: ORPHA181368
DOI: 10.1016/j.cels.2022.12.005 Keywords: African American,European American,adipose,eQTL,gene causal network,gene co-expression network,gene module,insulin resistance,key driver,muscle
MTG3

Potentialities of Gene Therapy in Pediatric Endocrinology


Author(s): Frontino G, Stancampiano MR, Aiuti A
Affiliated Institution / ERN: Semmelweis University ;
Condition / Disease: Rare endocrine conditions
Publication: Hormone Research in Paediatrics v96.6 p646-657 Year: 2023 ORPHAcode / other: ORPHA97978
DOI: 10.1159/000520965 Keywords: Gene therapy,Monogenic disease,Pediatric endocrine disease,Type 1 diabetes
MTG1 MTG2 MTG3 MTG4 MTG5 MTG6 MTG7 MTG8

Deescalating Follow-up After Hemithyroidectomy for Patients With Low-risk Papillary Thyroid Microcarcinoma


Author(s): van Dijk SPJ, Coerts HI, Lončar I, Verhoef C, Kruijff S, Engelsman AF, Peeters RP, van Ginhoven TM
Affiliated Institution / ERN: University Medical Center Groningen ;
Condition / Disease: Follicular thyroid carcinoma
Publication: JAMA Otolaryngology–Head & Neck Surgery v149.1 p42 Year: 2023 ORPHAcode / other: ORPHA146
DOI: 10.1001/jamaoto.2022.3686 Keywords:
MTG8

Pubertal and Gonadal Outcomes in 46,XY Individuals with Partial Androgen Insensitivity Syndrome Raised as Girls


Author(s): Guaragna-Filho G, Guerra-Junior G, Tadokoro-Cuccaro R, Hughes IA, Barros BA, Hiort O, Balsamo A, Guran T, Holterhus PM, Hannema S, Poyrazoglu S, Darendeliler F, Bryce J, Ahmed SF, Quigley CA
Affiliated Institution / ERN: Universitätsklinikum Schleswig-Holstein ;
Condition / Disease: Partial androgen insensitivity syndrome
Publication: Sexual Development v17.1 p16-25 Year: 2023 ORPHAcode / other: ORPHA754; ORPHA90797;
DOI: 10.1159/000526997 Keywords: Androgen insensitivity syndrome,Differences of sex development,Disorders of sex development,Partial androgen insensitivity syndrome,Puberty

Testicular Architecture of Men with 46,XX Testicular Disorders of Sex Development


Author(s): Hiort M, Rohayem J, Knaf R, Laurentino S, Berglund A, Gravholt CH, Gromoll J, Wistuba J
Affiliated Institution / ERN: Aarhus University Hospital ;
Condition / Disease: 46XX Testicular Disorders of Sex Development
Publication: Sexual Development v17.1 p32-42 Year: 2023 ORPHAcode / other: ORPHA325546
DOI: 10.1159/000528955 Keywords: 46,XX TDSD,Leydig cells,Sertoli cells,Testis histology
MTG7

Availability and access to pediatric diabetes care: a global descriptive study


Author(s): Pulungan AB, de Beaufort C, Ratnasari AF, Puteri HA, Lewis-Watts L, Bhutta ZA
Affiliated Institution / ERN: Centre Hospitalier de Luxembourg ;
Condition / Disease: pediatric diabetes care
Publication: Clinical Pediatric Endocrinology v32.3 p137-146 Year: 2023 ORPHAcode / other: ORPHA101952
DOI: 10.1297/cpe.2023-0017 Keywords: access,availability,children,diabetes,type 1 diabetes mellitus (T1DM)
MTG3

Type 1 diabetes mellitus prevention


Author(s): Groele L, Szypowska A
Affiliated Institution / ERN: Public Pediatric Teaching Hospital ;
Condition / Disease: diabetes type 1
Publication: Pediatric Endocrinology Diabetes and Metabolism v29.4 p209-213 Year: 2023 ORPHAcode / other:
DOI: 10.5114/pedm.2023.134130 Keywords: b cell.,prevention,diabetes mellitus
MTG3

The views of teenagers with obesity, their caregivers, and doctors: a plain language summary of the ACTION Teens global survey


Author(s): Mooney V, Baur LA, Bereket A, Bin-Abbas B, Chen W, Fernández-Aranda F, Nieto NG, López Siguero JP, Maffeis C, Osorto CK, Reynoso R, Rhie Y, Toro-Ramos M, Halford JC
Affiliated Institution / ERN: AOUI Verona ;
Condition / Disease: obesity
Publication: Journal of Comparative Effectiveness Research v12.1 Year: 2023 ORPHAcode / other: ORPHA77828
DOI: 10.2217/cer-2022-0164 Keywords: adolescents,caregivers,doctors,healthcare professionals,lay summary,obesity,plain language summary,survey,teenagers,weight,weight management
MTG5

The transition from pediatric to adult care in individuals with Prader-Willi syndrome


Author(s): Poitou C, Holland A, Höybye C, de Graaff LCG, Bottius S, Otterlei B, Tauber M
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ;
Condition / Disease: Prader Willi syndrome
Publication: Endocrine Connections v12.1 Year: 2023 ORPHAcode / other: ORPHA739
DOI: 10.1530/ec-22-0373 Keywords: Prader-Willi syndrome,transition
MTG5

Lessons Learned from 17 Years of Multidisciplinary Care for Differences of Sex Development Patients at a Single Indonesian Center


Author(s): Faradz SM, Listyasari N, Utari A, Ariani MD, Juniarto AZ, Santosa A, Ediati A, Rinne TK, Westra D, Claahsen-van der Grinten H, de Jong FH, Drop SL, Ayers K, Sinclair A
Affiliated Institution / ERN: Radboud University Medical Centre Nijmegen ;
Condition / Disease: DSD
Publication: Sexual Development v17.4-6 p170-180 Year: 2023 ORPHAcode / other: ORPHA98085; ORPHA2982; ORPHA325546;
DOI: 10.1159/000534085 Keywords: Chromosomes,Disorders of sex development,Genes,Indonesia,Multidisciplinary team
MTG7

Abstracts of the 2023 Pediatric Endocrine Society (PES) Annual Meeting’ to Hormone Research in Paediatrics


Author(s): Program Chairs, PES 2023 Annual Meeting Dr. Leena Nahata, Columbus, OH Dr. Takara Stanley, Boston, MA
Affiliated Institution / ERN: Beaumont & CHI - Dublin ;
Condition / Disease: growth hormone deficiency
Publication: Hormone Research in Paediatrics v96.Suppl. 3 p1-399 Year: 2023 ORPHAcode / other: ORPHA101957; ORPHA95488
DOI: 10.1159/000531602 Keywords:
MTG6

Growth Hormone Dose Modulation and Final Height in Short Children Born Small for Gestational Age: French Real-Life Data


Author(s): Coutant R, Leheup B, Nicolino M, Salles J
Affiliated Institution / ERN: CHU d'Angers ;
Condition / Disease: Growth Hormone Dose Modulation
Publication: Hormone Research in Paediatrics v96.5 p495-508 Year: 2023 ORPHAcode / other: ORPHA90692; ORPHA631;
DOI: 10.1159/000530572 Keywords: Dose modulation,Growth hormone,Real-world data,Small for gestational age
MTG5

Challenges Waiting for an Adult with DSD


Author(s): Nowotny HF, Reisch N
Affiliated Institution / ERN: Klinikum der Universität München ;
Condition / Disease: DSD
Publication: Hormone Research in Paediatrics v96.2 p207-221 Year: 2023 ORPHAcode / other: ORPHA98085; ORPHA2982; ORPHA325546;
DOI: 10.1159/000527433 Keywords: 46,XY DSD,Adult care,Androgen insensitivity syndrome,Comorbidities,Congenital adrenal hyperplasia,Disorders/differences of sex development,Gonadal dysgenesis,Klinefelter syndrome,Long-term outcome,Transition,Turner syndrome
MTG7
Page 14 of 32« First«...1213141516...2030...»Last »

Endo-ERN Newsletter

Subscribe to our newsletter to receive updates on all network activities and new resources. As soon as you subscribe you will receive an email asking you to confirm your registration.

SIGN UP NOW

News

  • All news
  • Newsletter signup

Events

  • Upcoming events
  • Webinars

Information

  • About Us
  • Contact
  • FAQs

Social Links

Linkedin Facebook Youtube

Contact

Endo-ERN
Coordinating Center
Meibergdreef 9
1105 AZ AMSTERDAM
The Netherlands

info@endo-ern.eu
Funded by the European Union
©2026. All Rights Reserved. Endo-ERN

Privacy Policy – GDPR

Website design by Elan Creative

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Information video for patients and healthcare professionals

Type and Press “enter” to Search

Search
Privacy Overview
Endo-ERN

Endo-ERN Privacy Policy

Endo-ERN is committed to user’s privacy and does not track personal data when visiting our website. We act in accordance with Regulation 2016/679 of the European Parliament and of the Council.

‘Personal data’ means any information relating to an identified or identifiable natural person. An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as:

  • a name
  • an identification number
  • location data
  • an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person

Cookies

Endo-ERN only tracks anonymised data for statistical purposes. We do this via analytical cookies, placed through an anonymous IP Google analytics tag. The purpose of these cookies are to track the efficiency and success of the website.

These cookies do not store any personal data that can be linked to a natural person, but may save data such as inter alia, data about the website from which a person has come (the so-called referrer), which sub-pages were visited, or how often and for what duration a sub-page was viewed. The data collected through this is general data only, and cannot be traced back to one person.

It is possible to prevent the setting of cookies, by means of a setting of the Internet browser used. On top of that, already set cookies may be deleted at any time via an Internet browser or other software programs. This is possible in all popular Internet browsers.

Google Analytics does not share any data with third parties.

The principles of data protection do not apply to anonymous information and because these cookies minimally impact the privacy of the user, it is not necessary to ask for permission to use these cookies.

Newsletter

You may always unsubscribe from our newsletter at any time through the unsubscribe button located in our newsletter. Endo-ERN is both the controller and responsible for processing of any data regarding the newsletter. Endo-ERN does not make use of a third party for the Newsletter service.

E-services

Endo-ERN has a contact form, which activates your email software and allows you to send a comment or question to a general email address. When you send such a message, your personal data is collected only to the extent necessary to reply. If the team responsible for the mailbox is unable to answer your question, or your questions has regards to another party, it might forward your email to another service.

If you have any questions about the processing of your email and related personal data, do not hesitate to include them in your message.

The collected personal data and all information related to the above mentioned consultation is stored on the email server of the Endo-ERN Coordinating office and potentially those who have been concerned in the correspondence in order to respond to your comment.

Newsletter Tracking

The Endo-ERN newsletter makes use of tracking in order to be able to conduct a statistical analysis of the success or failure of online marketing campaigns. Endo-ERN may see if an email containing a newsletter was opened by a user, when it was opened, and which links were opened. 
The data collected through this tracking is generated and stored by Endo-ERN and is not shared with third parties, but may be used to adapt future content of newsletters in order to better meet the interests of our subscribers.

Contact details

For any questions regarding our privacy policy, please contact the Endo-ERN coordinating office.

You have the right to be forgotten and removed completely from the Endo-ERN contact database. To request this, please contact the Endo-ERN coordinating office.

Endo-ERN Coordinating Center, Meibergdreef 9, 1105 AZ  AMSTERDAM. The Netherlands

 info@endo-ern.eu
Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Powered by  GDPR Cookie Compliance